Biontech Cell&gene Therapies Gmbh opposition analysis

COMPANY ANALYSIS

Latest patents of Biontech Cell&gene Therapies Gmbh opposed by its competitors

Patent:
Grant Date:
Jul 26, 2023
Title:
Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination
Oppositions:
1
Patent:
Grant Date:
Feb 16, 2022
Title:
Claudin-6-Specific Immunoreceptors And T Cell Epitopes
Oppositions:
1
Patent:
Grant Date:
Sep 2, 2020
Title:
Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes
Oppositions:
1

Want to track Biontech Cell&gene Therapies Gmbh?

Feel free to send us a message here and we will get back to you